Clade I mpox vaccination: strategies for deployment and evaluation

Clade I mpox continues to spread in Central Africa with no sign of abating,1 however very few doses of vaccine have been deployed. Mpox vaccination strategies using either of the licenced vaccines, MVA-BN and LC16m8, are being drawn up across 17 African countries and vaccination has begun in the Democratic Republic of Congo (DRC), Rwanda and Nigeria.2 Clinical studies during the rollout could deliver much-needed data about the effectiveness of the vaccine against clade I mpox. Choosing the right study design is fundamental.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2025-08-20
DOI
https://doi.org/10.1016/j.ebiom.2025.105890
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clade I mpox vaccination: strategies for deployment and evaluation

M. Grabowski, Chris Wymant, Marc Lipsitch, Christophe Fraser et al.
EBioMedicine
SARS-CoV-2 and COVID-19 Research
article

Clade I mpox vaccination: strategies for deployment and evaluation

M. Grabowski, Chris Wymant, Marc Lipsitch, Christophe Fraser, Francesco Di Lauro, Ronald Moses Galiwango, Robert Hinch, Jasmina Panovska‐Griffiths, Lucie Abeler‐Dörner, Deogratius Ssemwanga, Luca Ferretti, Jake Dunning, Caitlin Pley, Joseph Kagaayi, Pontiano Kaleebu, James A. Hay
article en

Abstract

Clade I mpox continues to spread in Central Africa with no sign of abating,1 however very few doses of vaccine have been deployed. Mpox vaccination strategies using either of the licenced vaccines, MVA-BN and LC16m8, are being drawn up across 17 African countries and vaccination has begun in the Democratic Republic of Congo (DRC), Rwanda and Nigeria.2 Clinical studies during the rollout could deliver much-needed data about the effectiveness of the vaccine against clade I mpox. Choosing the right study design is fundamental.

EBioMedicineVol. 119
Harvard University (US), University of Oxford (GB), Rakai Health Sciences Program (UG), Jenner Institute (GB), Makerere University (UG), Uganda Virus Research Institute (UG)
Coalition for Epidemic Preparedness Innovations, University of Oxford, Precursory Research for Embryonic Science and Technology
Openalex Percentile: Top 74%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.